Avenue Therapeutics (ATXI) Interest & Investment Income (2017 - 2026)
Avenue Therapeutics (ATXI) posted Interest & Investment Income of $17,000 for Q2 2026, down 45.2% from $31,000 a year earlier and down 5.6% from the prior quarter.
Powered by 
Analysis
Avenue Therapeutics (ATXI) Interest & Investment Income (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Avenue Therapeutics was $94,000, down 31.9% year-over-year; for FY2025, it came in at $121,000, down 31.3% from FY2024.
- Annual Interest & Investment Income shows a five-year compound annual growth rate of 14.3% (FY2020 to FY2025).
- In prior years, Avenue Therapeutics' Interest & Investment Income was $176,000 in FY2024 (+39.7%), $126,000 in FY2023 (+530.0%), $20,000 in FY2022 (+185.7%) and $7,000 in FY2021 (-88.7%).
- The Q2 2026 figure stands as the lowest quarterly Interest & Investment Income since Q3 2023.
- On a year-over-year basis, Interest & Investment Income increased in three of the last eight quarters, with growth averaging 35.3%.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q3 2023, with growth of 800.0%; the weakest was Q3 2021, with a decline of 88.9%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $18,000 (Q1 2026), $25,000 (Q4 2025) and $34,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Avenue Therapeutics | 1.32 Mn | -9.61 Mn | - | 17,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 52,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Jun 30, 2023 | 57,000.00 |
| Mar 31, 2023 | 37,000.00 |
| Dec 31, 2022 | 16,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
API Access
Avenue Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ATXI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ATXI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ATXI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();